411080 — Sands Lab Income Statement
0.000.00%
- KR₩95bn
- KR₩62bn
- KR₩12bn
Annual income statement for Sands Lab, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.
2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | 2025 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | PROSPECTUS | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 5,414 | 9,300 | 11,722 | 8,297 | 11,612 |
| Selling / General / Administrative Expenses | |||||
| Research And Development | |||||
| Depreciation and Amortization | |||||
| Other Operating Expenses | |||||
| Total Operating Expenses | 4,925 | 7,210 | 12,606 | 12,006 | 13,382 |
| Operating Profit | 489 | 2,089 | -884 | -3,709 | -1,770 |
| Gain / Loss on Sale of Assets | |||||
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | 546 | 2,114 | 13 | -2,787 | -37 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | 734 | 2,155 | 439 | -2,301 | -465 |
| Minority Interest | |||||
| Net Income Before Extraordinary Items | |||||
| Net Income | 734 | 2,155 | 439 | -2,301 | -550 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | 734 | 2,155 | 439 | -2,301 | -550 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | 56.8 | 167 | 33 | -162 | -36.4 |
| Dividends per Share |